Drugs / AR-17043
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT06441643 | Sep 2024 → Nov 2025 | ocular hypertension, open-angle glaucoma | Alcon Research | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | AR-17043 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT06441643 ↗ |
| Route | Other | “AR-17043 Ophthalmic Solution, one drop in each eye in the evening on Days 1-28.” NCT06441643 ↗ |